BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the...
MOBILE, Ala.--(BUSINESS WIRE)--The Company formerly known as CPSI has officially rebranded and changed its name to TruBridge, Inc. (“TruBridge”), effective...
NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President...
44 ALLY® Adaptive Cataract Treatment Systems were placed in 2023, significantly exceeding the target of 30, increasing the ALLY installed...
SEATTLE, WA / ACCESSWIRE / March 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that...
Omaha-based Fusion was awarded for two large marketing projects that were unveiled in late 2023.OMAHA, NE / ACCESSWIRE / March...
CHANTILLY, VA / ACCESSWIRE / March 4, 2024 / Cipher Surgical, a leading innovator in medical device technology, is pleased...
Former CIO and CHIME leader David Finn joins First Health Advisory to support clients with policy changes facing the healthcare...
LAVAL, QC / ACCESSWIRE / March 4, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced...
JEFFERSONVILLE, IN / ACCESSWIRE / March 4, 2024 / PharmaCord, a leading provider of patient services and commercialization solutions to...
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with...
Leading Podiatrist, Cameron Neilson, DPM, joins the Ankle & Foot Centers of America in Loganville, GA. Dr. Neilson is among...
KELOWNA, BC / ACCESSWIRE / March 4, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
ORLANDO, FL / ACCESSWIRE / March 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription...
NEW YORK and LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, specializing in state-of-the-art image enhancement and precision...
Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for...
-- Company Expects to Announce Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series by the End of the...
JERUSALEM, March 04, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of...
MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis...